Alogliptin, but not voglibose, ameliorates dyslipidemia and LDL particle size in patients with impaired glucose tolerance or Type 2 diabetes

Clinical Lipidology , October 2013, Vol. 8, No. 5, Pages 533-540.
Source: Future Medicine: Clinical Lipidology - Category: Lipidology Tags: article Source Type: research